Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancer

S. Blagden, A. Hamilton, Linda Mileshkin, M. Hall, T. Meniawy, S. Wong, S. Anandra, M. Buck, D. McAleer, B. A. Reedy, R. B. Noble, D. A. Smith, S. R. Morris, H. Gabra

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)7-7
Number of pages1
JournalEuropean Journal of Cancer
Volume50
DOIs
Publication statusPublished - Nov 2014
Event26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Barcelona, Spain
Duration: 18 Nov 201421 Nov 2014

Cite this